These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 33655862

  • 1. Anti-breast Cancer Potential of Natural and Synthetic Coumarin Derivatives.
    Song F, Huo X, Guo Z.
    Curr Top Med Chem; 2021; 21(18):1692-1709. PubMed ID: 33655862
    [Abstract] [Full Text] [Related]

  • 2. Coumarin derivatives with anticancer activities: An update.
    Song XF, Fan J, Liu L, Liu XF, Gao F.
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [Abstract] [Full Text] [Related]

  • 3. Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review.
    Wang G, Sun S, Wu B, Liu J.
    Curr Top Med Chem; 2021 Aug; 21(19):1725-1736. PubMed ID: 33185162
    [Abstract] [Full Text] [Related]

  • 4. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S, Dadashpour S.
    Eur J Med Chem; 2015 Sep 18; 102():611-30. PubMed ID: 26318068
    [Abstract] [Full Text] [Related]

  • 5. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
    Yan G, Luo J, Han X, Zhang W, Pu C, Zhou M, Zhong X, Hou X, Hou MZ, Li R.
    Anticancer Agents Med Chem; 2021 Sep 18; 21(17):2351-2367. PubMed ID: 33511941
    [Abstract] [Full Text] [Related]

  • 6. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.
    Zheng L, Gao T, Ge Z, Ma Z, Xu J, Ding W, Shen L.
    Eur J Med Chem; 2021 Mar 15; 214():113226. PubMed ID: 33582387
    [Abstract] [Full Text] [Related]

  • 7. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells.
    Li Y, Tang Q, Xie Y, He D, Yang K, Zheng L.
    Bioorg Med Chem Lett; 2021 Feb 01; 33():127750. PubMed ID: 33340662
    [Abstract] [Full Text] [Related]

  • 8. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.
    Tugcu G, Sipahi H, Aydin A.
    Curr Top Med Chem; 2019 Feb 01; 19(13):1121-1128. PubMed ID: 31210111
    [Abstract] [Full Text] [Related]

  • 9. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R, Hou Z, Li JT, Yu HN, Mou YH, Guo C.
    Molecules; 2018 Sep 06; 23(9):. PubMed ID: 30200625
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
    Yu H, Hou Z, Tian Y, Mou Y, Guo C.
    Eur J Med Chem; 2018 May 10; 151():434-449. PubMed ID: 29649740
    [Abstract] [Full Text] [Related]

  • 11. Coumarin-containing hybrids and their anticancer activities.
    Zhang L, Xu Z.
    Eur J Med Chem; 2019 Nov 01; 181():111587. PubMed ID: 31404864
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of synthetic coumarins for antiausterity cytotoxicity against pancreatic cancers.
    Farley CM, Dibwe DF, Ueda JY, Hall EA, Awale S, Magolan J.
    Bioorg Med Chem Lett; 2016 Mar 01; 26(5):1471-4. PubMed ID: 26832787
    [Abstract] [Full Text] [Related]

  • 13. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC, Liu ZP.
    Anticancer Agents Med Chem; 2017 Mar 01; 17(3):395-403. PubMed ID: 26902599
    [Abstract] [Full Text] [Related]

  • 14. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
    Elshemy HAH, Zaki MA.
    Bioorg Med Chem; 2017 Feb 01; 25(3):1066-1075. PubMed ID: 28038941
    [Abstract] [Full Text] [Related]

  • 15. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
    Dlugosz A, Gach-Janczak K, Szymanski J, Deredas D, Krawczyk H, Janecki T, Janecka A.
    Anticancer Agents Med Chem; 2018 Feb 01; 18(3):450-457. PubMed ID: 28933263
    [Abstract] [Full Text] [Related]

  • 16. Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized.
    Wang H, Xu W.
    Biochem Biophys Res Commun; 2017 Jul 15; 489(1):1-7. PubMed ID: 28546001
    [Abstract] [Full Text] [Related]

  • 17. Novel inhibitors of human histone deacetylases: design, synthesis and bioactivity of 3-alkenoylcoumarines.
    Seidel C, Schnekenburger M, Zwergel C, Gaascht F, Mai A, Dicato M, Kirsch G, Valente S, Diederich M.
    Bioorg Med Chem Lett; 2014 Aug 15; 24(16):3797-801. PubMed ID: 25042254
    [Abstract] [Full Text] [Related]

  • 18. Discovery of coumarin-monastrol hybrid as potential antibreast tumor-specific agent.
    Sashidhara KV, Avula SR, Sharma K, Palnati GR, Bathula SR.
    Eur J Med Chem; 2013 Feb 15; 60():120-7. PubMed ID: 23287057
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, antiproliferative activities, and DNA binding of coumarin-3-formamido derivatives.
    Shi J, Lu W, Chen J, Sun L, Yang S, Zhou M, Xu L, Ma Y, Yu L.
    Arch Pharm (Weinheim); 2021 Feb 15; 354(2):e2000236. PubMed ID: 33079446
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and cytotoxic activity of non-naturally substituted 4-oxycoumarin derivatives.
    Serra S, Chicca A, Delogu G, Vázquez-Rodríguez S, Santana L, Uriarte E, Casu L, Gertsch J.
    Bioorg Med Chem Lett; 2012 Sep 15; 22(18):5791-4. PubMed ID: 22901895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.